|Written by GSCR Staff|
|Thursday, 03 January 2013 09:13|
OK, now that ‘cliff-mania’ has subsided somewhat, it’s time to get back to basics. In other words, let’s identify some cheap stocks that look poised to move much higher. Even with yesterday’s monster move, there are still some great plays out there.
One sector that took it on the chin last year but looks like it is ready to rock is the semiconductor industry. This is very much a cyclical business, as revenue can be tied to an overall uptick in economic expansion and growth, and it was not the place to be in 2012. Even the bellwether, Intel (NYSE – INTC - $21.34), is hovering around the $20 range, not too far off the 52-week low of $19.23 with a FY12E P/E under 10. The slowing PC business and slower manufacturing abroad had an impact on INTC and many of the semi businesses’ customers last year. That is expected to change for some of these players in 2013, however.
Shifting business trends and cheap stocks should change sentiment in semis to at least “semi-bullish” and later bullish, especially with certain semi capital equipment providers. Here are 2 for you daily goodie bag:
Photronics Inc. (NASDAQ – PLAB - $6.04) is a manufacturer and supplier of photomasks which are used in both the semiconductor, flat panel displays. Our channel check sin the flat panel space indicate that orders should be big in the first half of the year for the industry in general, which plays to PLAB’s strength.
Founded in 1969, PLAB has been around “forever” and has a FY13E P/E of 15.0 compared to an 18.8 average for some of its peers. From a technical perspective, both the long term and short term indicators are on the plus side. EPS is expected to really see a big upward swing later this year.
Obviously, we are not alone in liking the stock. Hedgie player Steelhead Partners filed a 13G stating it now owns 6.4% of the stock. That should give it a boost today. Looking ahead, we see the stock climbing back to the 52-week high it hit back in February 2012 of $7.70 in the coming weeks.
Another oldie but goodie is Amkor Technology Inc. (NASDAQ – AMKR - $4.44), which was founded in 1968 and provides semiconductor packaging and test services. With revenue of over $2.7 billion this small cap stock is no small player. Moreover, the valuation here is arguably even more compelling than with the price/revenue P/E afforded PLAB.
EPS is expected to jump by more than 50% from 2012 to 2013. Estimates call for $0.39 in 2012 and $0.61 on 2013, representing a P/E below 8x for next year! The chart is trending higher as the stock has climbed steadily from a floor of $3.65 in November and should continue its ascent. Look for a $6.00 target in the not too distant future.
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com